TMDX SEC Filings: 8-K, 10-Q, S-3 & 424B – TransMedics

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 4, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 5, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 24, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 29, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Jul 30, 2025

News

TYPE

HEADLINE

FILED AT

8-K

TransMedics Reports Third Quarter 2026 Results and Raises Full-Year Guidance

Nov 5, 2026

8-K

TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook

Sep 10, 2026

8-K

TransMedics Reports Second Quarter 2026 Financial Results

Aug 4, 2026

8-K

TransMedics Group, Inc. Announces Results of 2026 Annual Meeting of Shareholders

May 21, 2026

8-K

TransMedics Reports First Quarter 2026 Financial Results

May 5, 2026

8-K

TransMedics Provides Details on Impact of Valuation Allowance Release on Q4 2025 Tax Results

Feb 27, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

3,250,000 Shares

Aug 5, 2022

424B5

Risks Related to Our Common Stock and this Offering

Aug 3, 2022

424B5

Risks Related to Our Common Stock and this Offering

May 27, 2020

424B5

Risks Related to Our Common Stock and this Offering

May 26, 2020

424B4

Risks Related to Our Common Stock and this Offering

May 2, 2019

Registrations

TYPE

HEADLINE

FILED AT

S-8

Registration

Aug 4, 2023

S-3ASR

Common Stock

Aug 3, 2022

S-8

Registration

Mar 1, 2022

S-3

Common Stock

May 6, 2020

S-8

Registration

May 6, 2019

S-1MEF

Registration

May 1, 2019

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

May 7, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 10, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 10, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 10, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 10, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 10, 2024

Ownerships

TYPE

HEADLINE

FILED AT

144

NEWForm 144 - Report of proposed sale of securities

Nov 9, 2026

Araujo Fernando N. (Reporting)

Oct 30, 2026

Araujo Fernando N. (Reporting)

Sep 29, 2026

Weill David (Reporting)

Sep 14, 2026

TOBIN JAMES R (Reporting)

Aug 17, 2026

Corcoran Nicholas (Reporting)

Jul 14, 2026

Other

TYPE

HEADLINE

FILED AT

Form SD - Specialized disclosure report

May 29, 2026

Form SD - Specialized disclosure report

May 30, 2025

Form SD - Specialized disclosure report

May 31, 2024

EFFECT

Form EFFECT - Notice of Effectiveness

May 22, 2020

CORRESP

Form CORRESP - Correspondence

May 19, 2020

CORRESP

Form CORRESP - Correspondence

May 19, 2020

TransMedics Group, Inc. TMDX · SEC Filings